SCA
IBB icon

Snowden Capital Advisors’s iShares Biotechnology ETF IBB Stock Holding History

Snowden Capital Advisors’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.17M Buy
6,939
+1,029
+17% +$176K 0.03% 481
2025
Q4 		$998K Buy
5,910
+71
+1% +$11.5K 0.03% 530
2025
Q3 		$843K Buy
5,839
+23
+0.4% +$3.14K 0.02% 579
2025
Q2 		$736K Sell
5,816
-27
-0.5% -$3.31K 0.02% 611
2025
Q1 		$747K Sell
5,843
-494
-8% -$67K 0.02% 600
2024
Q4 		$838K Buy
6,337
+121
+2% +$17K 0.03% 567
2024
Q3 		$905K Sell
6,216
-167
-3% -$24.2K 0.03% 545
2024
Q2 		$876K Buy
6,383
+130
+2% +$17.4K 0.03% 548
2024
Q1 		$858K Buy
6,253
+1,960
+46% +$268K 0.03% 549
2023
Q4 		$583K Buy
4,293
+301
+8% +$36.7K 0.02% 636
2023
Q3 		$488K Sell
3,992
-1,712
-30% -$218K 0.02% 668
2023
Q2 		$724K Buy
5,704
+72
+1% +$9.35K 0.03% 570
2023
Q1 		$727K Buy
5,632
+3
+0.1% +$393 0.03% 563
2022
Q4 		$739K Buy
5,629
+46
+0.8% +$5.95K 0.03% 535
2022
Q3 		$652K Buy
5,583
+235
+4% +$29.2K 0.03% 554
2022
Q2 		$629K Sell
5,348
-328
-6% -$38.9K 0.03% 543
2022
Q1 		$739K Buy
5,676
+1,612
+40% +$210K 0.03% 516
2021
Q4 		$620K Buy
4,064
+683
+20% +$106K 0.03% 414
2021
Q3 		$547K Sell
3,381
-1,966
-37% -$331K 0.03% 512
2021
Q2 		$875K Buy
5,347
+1,787
+50% +$275K 0.04% 401
2021
Q1 		$536K Sell
3,560
-10,206
-74% -$1.62M 0.03% 476
2020
Q4 		$2.09M Sell
13,766
-100
-0.7% -$14.3K 0.14% 205
2020
Q3 		$1.88M Sell
13,866
-562
-4% -$76.2K 0.15% 191
2020
Q2 		$1.97M Sell
14,428
-343
-2% -$43.7K 0.17% 179
2020
Q1 		$1.59M Sell
14,771
-582
-4% -$67K 0.17% 178
2019
Q4 		$1.85M Sell
15,353
-4,667
-23% -$521K 0.16% 185
2019
Q3 		$1.99M Buy
20,020
+874
+5% +$91.5K 0.2% 160
2019
Q2 		$2.09M Buy
19,146
+101
+0.5% +$10.7K 0.21% 160
2019
Q1 		$2.13M Buy
19,045
+992
+5% +$109K 0.23% 150
2018
Q4 		$1.74M Buy
18,053
+153
+0.9% +$16.2K 0.23% 161
2018
Q3 		$2.18M Buy
17,900
+577
+3% +$67.9K 0.25% 129
2018
Q2 		$1.9M Buy
17,323
+716
+4% +$76.6K 0.25% 133
2018
Q1 		$1.77M Buy
16,607
+634
+4% +$70.3K 0.26% 137
2017
Q4 		$1.71M Buy
15,973
+793
+5% +$84.8K 0.24% 137
2017
Q3 		$1.69M Buy
15,180
+858
+6% +$91.7K 0.27% 119
2017
Q2 		$1.48M Buy
14,322
+1,044
+8% +$103K 0.28% 124
2017
Q1 		$1.3M Sell
13,278
-6,432
-33% -$616K 0.29% 120
2016
Q4 		$1.74M Buy
19,710
+228
+1% +$20.8K 0.44% 72
2016
Q3 		$1.88M Buy
19,482
+10,647
+121% +$1.01M 0.51% 63
2016
Q2 		$758K Buy
8,835
+1,101
+14% +$98.8K 0.23% 152
2016
Q1 		$672K Buy
+7,734
New +$692K 0.23% 147

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Snowden Capital Advisors's IBB Position: Q1 2026 in Review

Snowden Capital Advisors increased its iShares Biotechnology ETF (IBB) stake by 17% in Q1 2026, buying an estimated $176K and bringing the position to 6,939 shares worth $1.17M. The position accounts for 0.03% of the portfolio, ranked #481.

Snowden Capital Advisors first reported a position in IBB in Q1 2016 and has held it in 41 quarters since. The position peaked at $2.18M in Q3 2018. 917 funds tracked by Wall St. Rank hold IBB as of Q1 2026.

  • Snowden Capital Advisors held 6,939 shares of iShares Biotechnology ETF worth $1.17M as of Q1 2026.
  • Snowden Capital Advisors bought 1,029 iShares Biotechnology ETF shares in Q1 2026, an estimated $176K.
  • iShares Biotechnology ETF made up 0.03% of Snowden Capital Advisors's portfolio in Q1 2026, its #481 holding.
  • Snowden Capital Advisors first reported a position in iShares Biotechnology ETF in Q1 2016 and has held it in 41 quarters since.
  • Snowden Capital Advisors's iShares Biotechnology ETF position peaked at $2.18M in Q3 2018.
  • 917 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.

Based on Snowden Capital Advisors's 13F filing for Q1 2026, filed 15 May 2026.